PTJ
NERV icon

Paul Tudor Jones’s Minerva Neurosciences NERV Stock Holding History

Paul Tudor Jones’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,750
Closed -$266K – 1202
2017
Q2 		$266K Buy
+3,750
New +$243K 0.01% 798
2016
Q3 		– Sell
-2,813
Closed -$230K – 1623
2016
Q2 		$230K Buy
+2,813
New +$179K ﹤0.01% 1328

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.37% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Paul Tudor Jones's NERV Position: Q3 2017 in Review

Paul Tudor Jones sold out of Minerva Neurosciences (NERV) in Q3 2017, closing a stake of 3,750 shares — an estimated $266K sold.

Paul Tudor Jones first reported a position in NERV in Q2 2016 and held it in 2 quarters. The position peaked at $266K in Q2 2017. 70 funds tracked by Wall St. Rank hold NERV as of Q3 2017.

  • Paul Tudor Jones reported no remaining Minerva Neurosciences position as of Q3 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 3,750 Minerva Neurosciences shares in Q3 2017, an estimated $266K.
  • Paul Tudor Jones first reported a position in Minerva Neurosciences in Q2 2016 and held it in 2 quarters.
  • Paul Tudor Jones's Minerva Neurosciences position peaked at $266K in Q2 2017.
  • 70 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.